Global Multi-Purpose SPECT Scanner Market Size By Type (Dynamic 3D Scanning, Multi-Purpose SPECT Scanner), By Application (Oncology, Cardiology), By Region, And Segment Forecasts, 2023 to 2032

The Global Multi-Purpose SPECT Scanner Market was valued at USD 3.2 billion in 2023 and is projected to surpass USD 5.6 billion by 2031, growing at a CAGR of 7.2% during the forecast period from 2023 to 2031. The rising prevalence of chronic diseases such as cardiovascular disorders, cancer, and neurological conditions is driving the demand for Single Photon Emission Computed Tomography (SPECT) scanners. These scanners play a crucial role in medical imaging, offering high precision in disease diagnosis and treatment planning.

The increasing adoption of hybrid imaging technology, advancements in radiopharmaceuticals, and growing investments in nuclear medicine infrastructure are further contributing to the market's expansion. Moreover, technological innovations such as AI integration and software advancements for image enhancement are boosting market growth.

Drivers

Rising Prevalence of Chronic Diseases

The increasing incidence of cardiovascular diseases (CVDs), cancer, and neurological disorders has heightened the demand for SPECT scanners in diagnostic applications.

Aging populations globally are further contributing to the increased need for advanced diagnostic tools.

Advancements in Imaging Technology

The integration of SPECT-CT and AI-powered imaging software has enhanced image resolution and diagnostic accuracy.

Development of automated and high-throughput scanners improves workflow efficiency.

Increasing Investments in Nuclear Medicine

Governments and private players are investing in radiopharmaceutical production and nuclear imaging centers, boosting the adoption of SPECT scanners.

The growing use of radiotracers in diagnosing complex diseases is further fueling market demand.

Restraints

High Costs of SPECT Scanners and Imaging Procedures

The initial capital investment required for multi-purpose SPECT scanners is significant, limiting adoption in small healthcare facilities.

The high cost of radiopharmaceuticals and maintenance expenses adds to operational costs.

Regulatory and Compliance Challenges

Stringent regulatory approvals for nuclear medicine procedures can delay market entry.

Compliance with radiation safety guidelines poses additional challenges for healthcare providers.

Opportunity

Growing Adoption in Emerging Markets

Asia-Pacific, Latin America, and the Middle East are witnessing increasing investments in healthcare infrastructure and nuclear medicine research, offering new growth avenues.

Government initiatives to expand radiology and oncology centers in these regions present lucrative opportunities.

Integration of AI and Machine Learning in Imaging

AI-powered imaging analysis is improving diagnostic accuracy and reducing scan time.

Machine learning algorithms help in real-time image reconstruction, enhancing diagnostic capabilities.

Market by System Type Insights

Based on system type, the Hybrid SPECT-CT Scanner segment dominated the market in 2023 and is expected to maintain its lead. The increasing preference for hybrid imaging due to its higher accuracy in disease localization and improved anatomical detail is fueling its demand. Standalone SPECT scanners are still widely used but are witnessing slower growth compared to hybrid variants.

Market by End-Use Insights

Hospitals

The hospital segment accounted for the largest market share in 2023, with over 50% of total revenue.

Increasing hospital investments in radiology and nuclear medicine departments is driving segment growth.

Diagnostic Imaging Centers

The demand for multi-purpose SPECT scanners in standalone diagnostic centers is rising due to increased outpatient diagnostics.

Growing partnerships between hospitals and imaging centers for specialized nuclear imaging services are supporting expansion.

Research Institutes

Academic and research institutions are increasingly utilizing SPECT scanners for neurological and oncological research.

The segment is projected to witness steady growth, driven by rising government and private sector funding for nuclear imaging research.

Market by Regional Insights

North America – Largest Market

The region held the largest market share in 2023, primarily due to strong healthcare infrastructure, advanced nuclear medicine research, and higher adoption of SPECT-CT systems.

The presence of key players like GE Healthcare, Siemens Healthineers, and Philips Healthcare strengthens the market in this region.

Asia-Pacific – Fastest Growing Market

Countries like China, India, and Japan are investing heavily in radiology and oncology imaging.

Increasing awareness of early disease detection and government funding for medical imaging centers is boosting demand.

Europe

European nations, particularly Germany, the UK, and France, have well-established nuclear medicine research centers, supporting market growth.

Stringent radiopharmaceutical regulations may, however, pose challenges.

Latin America & Middle East

Brazil, Mexico, and GCC countries are emerging as potential markets, driven by healthcare expansion and rising prevalence of chronic diseases.

Competitive Scenario

Key players in the Global Multi-Purpose SPECT Scanner Market include:

GE Healthcare

Siemens Healthineers

Philips Healthcare

Canon Medical Systems

Bracco Imaging

Curium

Digirad Corporation

Spectrum Dynamics Medical

These companies are focusing on technological advancements, strategic partnerships, and product innovation to strengthen their market position.

Key Market Developments

GE Healthcare launched an advanced AI-powered SPECT-CT scanner in 2023, designed to improve imaging speed and accuracy.

Siemens Healthineers introduced a compact multi-purpose SPECT system for smaller healthcare facilities in 2024.

Philips Healthcare expanded its nuclear imaging portfolio in 2025, incorporating AI-driven diagnostic tools.

Scope of Work – Global Multi-Purpose SPECT Scanner Market